Details for Luxembourg Supplementary Protection Certificate: LUC00249
Luxembourg Supplementary Protection Certificate: LUC00249
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2383297 | LUC00249 | Luxembourg | PRODUCT NAME: TAFASITAMAB; AUTHORISATION NUMBER AND DATE: EU/1/21/1570 20210901 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
